Diagnostic Medical Systems (FR:ALDMS) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Diagnostic Medical Systems (DMS) Group has reported a 13% increase in revenue for the third quarter of 2024, reaching €10 million, driven by strong performance in its Radiology and Osteodensitometry segments. The company’s total revenue for the first nine months of 2024 grew by 11%, with significant contributions from international markets.
For further insights into FR:ALDMS stock, check out TipRanks’ Stock Analysis page.